Senate Republicans blocked the $35 cap on out-of-pocket spending on insulin for patients enrolled in private insurance.
Why it matters: The drug costs eight times more in the U.S. than 32 other high-income nations, according to a 2020 study commissioned by the Health and Human Services Department.
What we're watching: The change to the climate, tax and healthcare package came during the amendment process that allows any senator to force a vote on proposed tweaks to the measure.
- Seven Republicans voted with Democrats to keep the insulin cap in the bill, but that was not enough to overcome the 60-vote threshold.
- The Republicans argued that the provision violated the rules of reconciliation after the Senate parliamentarian ruled that it is not primarily related to the federal budget.
Between the lines: Even though the $35 cap for the private insurers has been stripped from the package, Democrats are hoping to preserve the $35 insulin cap for patients on Medicare
The big picture: Capping out-of-pocket insulin costs — a narrow sliver of President Biden's stalled Build Back Better package — has been a priority for Democrats, particularly ahead of this year's midterms.
- It's also captured the attention of a few Republicans, leading to some bipartisan efforts to craft legislation.
from "price" - Google News https://ift.tt/XjPMhBY
via IFTTT
No comments:
Post a Comment